Filing summary
Issuer mismatch: The supplied filing is for Information Analysis Incorporated (IAI), not Firefly Neuroscience, Inc. It is a Form 10-K for the fiscal year ended December 31, 2020, filed March 31, 2021; it does not provide standalone fourth-quarter results.
Business context and financial performance
IAI provides IT modernization and professional services, third-party software, and related implementation and support, primarily to U.S. government customers. The financial statements cover fiscal years 2020 and 2019 and were audited; the auditor gave an unqualified opinion.
| Metric | 2020 | 2019 |
|---|---|---|
| Revenue | $13.90 million | $10.16 million |
| Professional fees | $5.53 million | $3.24 million |
| Software sales | $8.38 million | $6.92 million |
| Gross profit / margin | $2.21 million / 15.9% | $1.40 million / 13.8% |
| Operating income (loss) | $412,000 | $(728,000) |
| Net income (loss) | $413,000 | $(717,000) |
| Net cash from (used in) operations | $423,000 | $(917,000) |
Revenue rose 36.8%. Professional-fee revenue increased 70.4%, mainly as modernization subcontracts that had been delayed by protests began in June 2020. Software revenue grew 21.0%, but software sales remained low-margin; professional fees supplied most of the improvement in gross margin and the return to profitability. Selling, general and administrative expense fell to $1.50 million from $1.88 million.
Liquidity, debt, and other key facts
- Year-end cash and cash equivalents were $1.86 million, up $819,000; current assets were $3.44 million and current liabilities $1.80 million, for working capital of about $1.64 million.
- IAI received a $450,000 Paycheck Protection Program loan at 1% interest. It planned to seek full forgiveness, but forgiveness was uncertain and the lender had temporarily paused applications for loans over $150,000. The balance sheet reports $93,009 current and $356,991 noncurrent.
- The $1 million revolving credit line had no borrowings at year-end and expired July 31, 2021. IAI said it was in compliance with lender covenants.
- Backlog was estimated at $31.5 million over three years, but only $6.0 million was funded. The filing says backlog includes existing contracts and general client commitments.
- On March 29, 2021, after year-end, IAI raised approximately $496,000 by issuing 330,666 shares for working capital and anticipated expansion.
Outlook, commentary, and risks
Management said delayed subcontracts and additional contracts lifted professional-fee revenue above the level it considered necessary to cover overhead, and described the business as being in a period of sustainable profitability. It planned to rebuild sales and business development and expand into cybersecurity, cloud services, and artificial intelligence; these are ambitions, not quantified guidance. Management expected existing cash and its operating plan to meet cash needs for at least one year from the filing date.
Key risks include dependence on federal procurement and a limited number of contracts, government termination and funding discretion, significant software-supplier and customer concentration, competition, staffing and contract-cost estimation, and execution risk in new service areas. A single prime contractor represented 28.7% of 2020 revenue in aggregate across multiple subcontracts; one software supplier accounted for 58.4% of revenue. COVID-19 had minimal reported impact on existing work to date, but management said effects on business development and future operations remained uncertain. Forms modernization opportunities at existing customers were nearing maturity. The company also described limited trading volume and a limited public market for its stock.
Important facts for investors to verify
- Confirm the intended issuer: this filing is IAI’s, not Firefly Neuroscience’s.
- Check subsequent results for whether the 2020 profitability continued and whether backlog converted into funded, billable work.
- Verify PPP loan forgiveness status and repayment obligations, and the status or replacement of the revolving credit line after its July 2021 expiration.
- Assess the durability of revenue given federal contract, prime-contractor, and software-supplier concentration, plus the maturity of existing forms-modernization demand.
- Review the dilution implications of the March 2021 share placement and outstanding options; the filing reports 1.395 million options outstanding at year-end.